Technical Analysis for EVO - Evotec SE
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 1.25% | |
| Gapped Up | Strength | 1.25% | |
| Fell Below 20 DMA | Bearish | 6.35% | |
| Narrow Range Bar | Range Contraction | 6.35% | |
| Gapped Down | Weakness | 6.35% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.40% | |
| Narrow Range Bar | Range Contraction | 3.40% | |
| Crossed Above 20 DMA | Bullish | 2.97% | |
| Gapped Up | Strength | 5.65% | |
| 180 Bearish Setup | Bearish Swing Setup | 8.48% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 7 hours ago |
| Up 2% | about 9 hours ago |
| Rose Above Previous Day's High | about 10 hours ago |
| Up 1% | about 10 hours ago |
| Up 5% | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/14/2024
Evotec is an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry. Evotec's mission is to discover best and first-in-class medicines for a broad range of difficult to treat diseases in collaboration with our partners. Evotec has built a comprehensive suite of fully integrated, next generation technology platforms which it believes will transform the way new drugs are discovered. By leveraging the advanced capabilities of Evotec's integrated platforms, Evotec is able to provide solutions to its partners that enable significant improvements in the quality of new drugs while accelerating the drug discovery process and reducing the high cost of attrition often associated with traditional drug discovery processes.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Disease Health Sciences Drugs Natural Sciences Medication Drug Discovery Evotec
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Disease Health Sciences Drugs Natural Sciences Medication Drug Discovery Evotec
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.4924 |
| 52 Week Low | 3.94 |
| Average Volume | 178,312 |
| 200-Day Moving Average | 7.92 |
| 50-Day Moving Average | 5.08 |
| 20-Day Moving Average | 4.66 |
| 10-Day Moving Average | 4.54 |
| Average True Range | 0.20 |
| RSI (14) | 51.46 |
| ADX | 17.47 |
| +DI | 36.47 |
| -DI | 32.19 |
| Chandelier Exit (Long, 3 ATRs) | 4.39 |
| Chandelier Exit (Short, 3 ATRs) | 4.55 |
| Upper Bollinger Bands | 5.15 |
| Lower Bollinger Band | 4.18 |
| Percent B (%b) | 0.7 |
| BandWidth | 20.90 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.21 |
| MACD Histogram | 0.0805 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.05 | ||||
| Resistance 3 (R3) | 5.05 | 4.99 | 5.02 | ||
| Resistance 2 (R2) | 4.99 | 4.94 | 4.99 | 5.01 | |
| Resistance 1 (R1) | 4.93 | 4.91 | 4.96 | 4.92 | 5.00 |
| Pivot Point | 4.86 | 4.86 | 4.88 | 4.86 | 4.86 |
| Support 1 (S1) | 4.80 | 4.81 | 4.83 | 4.80 | 4.72 |
| Support 2 (S2) | 4.73 | 4.78 | 4.73 | 4.71 | |
| Support 3 (S3) | 4.67 | 4.73 | 4.70 | ||
| Support 4 (S4) | 4.67 |
